أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide (frusemide) -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hydrochlorothiazide,irbesartan -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hydrochlorothiazide,irbesartan -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hydrochlorothiazide,irbesartan -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - cabazitaxel acetone solvate -

اليابان - الإنجليزية - すりの適正使用協議会 RAD-AR Council, Japan

sanofi k.k. - spiramycin - white tablet, diameter: 10 mm, thickness: 5.5 mm

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - leflunomide 100mg - film coated tablet - 100 mg - active: leflunomide 100mg excipient: colloidal silicon dioxide crospovidone hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch povidone purified talc titanium dioxide - arava is indicated for the treatment of: · rheumatoid arthritis, to improve signs and symptoms to retard joint destruction and to improve functional ability and quality of life. leflunomide may be used in patients who have failed to respond to other treatments or as a first line of treatment in patients who have a contraindication to other treatments. · active psoriatic arthritis. arava is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - promethazine teoclate 25mg - tablet - 25 mg - active: promethazine teoclate 25mg excipient: dextrin lactose monohydrate magnesium stearate purified talc starch - prevention and treatment of travel sickness.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - ciclopirox 8% - nail lacquer - 8 % - active: ciclopirox 8% excipient: butyl ester of pvm/ma copolymer ethyl acetate isopropyl alcohol nitrogen

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - ciclopirox olamine 1%{relative} - topical cream - 1% w/w - active: ciclopirox olamine 1%{relative}